VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
An Exploratory, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Arbaclofen in Subjects with 16p11.2 deletion (Subaward)
Grant
Overview
date/time interval
July 1, 2024 - June 30, 2025
awarded by
Clinical Research Associates, LLC
administered by
Psychiatry
sponsor award ID
RFMH 251486-01
Affiliation
contributor
Tang, Karen
Principal Investigator (Subaward)
2024 - 2025